Latest Pr Implant Sciences Sells 12 QS-B220 Explosives

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
Latest Pr
Implant Sciences Sells
12 QS-B220 Explosives Trace Detectors to South Korea's Largest Airport



WILMINGTON, Mass. , Sept. 9, 2014 /PRNewswire/ -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has sold 12 QS-B220 desktop explosives and drugs trace detectors to Incheon International Airport Corporation, operator of Incheon International Airport , the largest airport in South Korea . Implant Sciences' ETDs will be deployed for airport security and will replace existing systems the airport had in place from a competitor.

"This customer was looking to replace a competing installed product with a more cost-efficient, high-performance ETD from a company that provides superior customer service and support," stated Dr. Darryl Jones , Implant Sciences' Vice President of Global Sales and Marketing. "This airport had been evaluating our QS-B220, but the sale was contingent upon our system being added to the TSA's Qualified Products List. Upon being placed on the TSA's QPL, the customer immediately placed their order."

"At Implant Sciences, our commitment to a culture of service is a priority and we believe it differentiates us in the market. Our local distributor, A&T, has a strong track record, is one of the most active leaders of the security market in South Korea , and will provide service and support to Incheon International Airport. We are pleased to work with them," Jones added.

About the QS-B220 Desktop Explosives and Drugs Trace Detector

The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives as well as illicit drugs. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

About Implant Sciences

Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company's team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 50 countries worldwide. Implant Sciences is only the third manufacturer, and the sole American-owned company, to currently have an ETD system named as a Qualified Product by the U.S. Transportation Security Administration. The Company's ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., STAC in France , the German Ministry of the Interior, and the Ministry of Public Safety in China . It also received a GSN 2013 Homeland Security Award for "Best Explosives Detection Solution". All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company's website at www.implantsciences.com .

Implant Sciences Corp. (IMSCQ) Stock Research Links

IMSCQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 86

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
Chemours Class Action: Key Deadline Approaches Fast

Updated Category News Views 77

A Rocky Ride for Chemours Investors The ticker might read NYSE:CC, but right now, that might as well stand for "Caution, Cautious," if you ask me. Investors are on high alert with Chemours facing a class action lawsuit, and the stakes couldn’t be higher. Deadline's looming on December 7, 2026, for those gunning for lead plaintiff status. It's a tense time for anyone who...

Continue Reading
Langford Chosen for Navy Mutual's 2026 Bolles Award

Updated Category News Views 225

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Continue Reading
Millrose Properties Faces Legal Storm: Investors Alerted

Updated Category News Views 187

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 157

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 65

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 116

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
UBCF Strikes Big in Times Square with New Billboards

Updated Category News Views 113

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 173

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 156

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading

Top 5 Most Recently Viewed Articles

EarthCam Unveils Revolutionary AI Camera for Construction Safety

Updated Category News Views 302

EarthCam Launches AI-Powered Mobile StreamCam Robotic EarthCam, a leader in visual technology, has unveiled its new Mobile StreamCam Robotic aimed at enhancing monitoring capabilities in interior construction. This innovative camera is designed to combine advanced live-streaming features with smart AI insights, providing construction teams with real-time data and...

Continue Reading
Investors Should Act Now: iLearningEngines Class Action News

Updated Category News Views 140

Understanding the iLearningEngines Class Action Lawsuit The well-regarded law firm Faruqi & Faruqi, LLP is currently inviting investors of iLearningEngines, Inc. to stay informed about an important class action lawsuit. This lawsuit revolves around allegations that iLearningEngines engaged in misleading practices fundamentally impacting its investors. The deadline to seek...

Continue Reading
Sarepta's Gene Therapy Under Investigation Following Tragic Death

Updated Category News Views 130

Investigation into Elevidys Following a Tragic Incident The U.S. Food and Drug Administration (FDA) has begun an investigation into the unfortunate death of a young boy who was administered Elevidys, Sarepta Therapeutics Inc.’s gene therapy designed for treating Duchenne muscular dystrophy. This announcement came after market close, raising concerns regarding the safety...

Continue Reading
2Rivers Group Enhances Market Position in West Africa

Updated Category News Views 56

2Rivers Group Expands Operations into West Africa 2Rivers Group is excited to announce its ongoing expansion into the West African market, reinforcing its status as a key entity in the global energy trading and distribution landscape. This initiative aligns perfectly with the company’s vision of achieving sustainable growth in important markets around the world....

Continue Reading
Pathward Financial Announces Upcoming Q1 2025 Earnings Call

Updated Category News Views 189

Pathward Financial to Announce Earnings for First Quarter 2025 Pathward Financial, Inc. has made an important announcement regarding its upcoming financial results for the first quarter of fiscal year 2025. The release is set for Tuesday, after the market closes, and the company is eager to share insights from these results. Conference Call Scheduled A conference call and...

Continue Reading